Compare Wegovy and Mounjaro Dosing Schedules
Understanding Wegovy Dose Equivalent to Mounjaro for Prescription Weight Loss
When comparing Wegovy dose equivalent to Mounjaro, it's essential to understand these aren't directly equivalent medications. Wegovy (semaglutide) is a GLP-1 receptor agonist, whilst Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist with different pharmacokinetics. Rather than seeking equivalent doses, patients should focus on each medication's unique escalation schedule and mechanism of action. Wegovy follows a structured 5-dose escalation: 0.25mg, 0.5mg, 1mg, 1.7mg, and 2.4mg maintenance, whilst Mounjaro uses four doses: 2.5mg, 5mg, 10mg, and 15mg maximum.
The concept of Wegovy dose equivalent to Mounjaro becomes less relevant when considering their different receptor targets and trial designs. Both prescription-only medicines demonstrated significant weight loss in their respective clinical trials, but direct comparisons aren't scientifically valid due to different study populations and methodologies. EverydayMeds provides both treatments through proper clinical assessment, allowing prescribers to recommend the most suitable option based on individual patient factors rather than dose equivalency assumptions.
Wegovy and Mounjaro Pricing Comparison at EverydayMeds
Understanding the cost implications when comparing Wegovy dose equivalent to Mounjaro helps patients make informed decisions. Wegovy pricing starts at £79.99 for the 0.25mg starter dose (with FIRST40 code for new customers), progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for the 2.4mg maintenance dose. Our Intro Trio bundle (0.25mg, 0.5mg & 1mg) provides the first 12 weeks for £299.99, whilst the Ultimate Stability Trio offers three months of 2.4mg maintenance for £649.99. Returning customers benefit from code DOSE25 at checkout across all doses and bundles.
When considering Wegovy dose equivalent to Mounjaro from a cost perspective, both treatments represent significant investment in prescription weight loss management. EverydayMeds' bundle options provide convenience rather than pure savings, ensuring consistent supply without multiple orders. The Intro Duo (0.25mg & 0.5mg) for £169.99 covers the critical first 8 weeks when side effect management is most important. Our pricing structure reflects the premium nature of these prescription-only medicines whilst maintaining accessibility through discount codes applied at checkout.
Clinical Evidence Behind Wegovy Dose Equivalent to Mounjaro Comparisons
The STEP clinical trial programme demonstrated Wegovy's efficacy across different populations. In STEP 1, participants achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo, whilst STEP 2 showed 9.6% weight reduction in patients with type 2 diabetes (Wilding et al., NEJM, 2021). STEP 3 combined Wegovy with intensive behavioural therapy for 16% average weight loss, and STEP 5 sustained 15.2% reduction at two years.
However, comparing clinical outcomes when discussing Wegovy dose equivalent to Mounjaro requires caution due to different trial designs and populations. Both treatments demonstrated significant weight loss in their respective studies, but head-to-head comparisons aren't scientifically valid. The SELECT cardiovascular outcomes trial showed Wegovy reduced major cardiovascular events by 20% (HR 0.80), providing additional benefits beyond weight management for eligible patients.
How Wegovy Works in Your Body
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone. When considering Wegovy dose equivalent to Mounjaro mechanisms, Wegovy specifically targets GLP-1 receptors in your brain's appetite centres, reducing hunger signals and promoting satiety after smaller meals. The medication slows gastric emptying, meaning food stays in your stomach longer, contributing to prolonged fullness. This mechanism may also reduce food cravings, particularly for high-calorie foods, supporting long-term weight management goals. Unlike Mounjaro's dual-hormone approach, Wegovy's single GLP-1 pathway provides targeted appetite regulation with a well-established safety profile from extensive clinical experience.
Starting Your Wegovy Treatment Through EverydayMeds
Beginning treatment when comparing Wegovy dose equivalent to Mounjaro options starts with our 3-minute online clinical assessment covering medical history, current medications, and weight management goals. Our registered prescribers review applications within 3 working days (express 24-hour service available), ensuring clinical suitability for this prescription-only medicine. Once approved, we dispatch Wegovy pens via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity. The assessment considers BMI requirements (≥30, or ≥27 with weight-related comorbidity) and contraindications, whilst our pharmacy team (GPhC #9012878) provides ongoing support throughout your treatment journey. Both Wegovy and Mounjaro are available through this streamlined process, with prescribers helping determine the most appropriate option.
Storage and Practical Considerations
When evaluating Wegovy dose equivalent to Mounjaro from a practical standpoint, storage requirements differ significantly between treatments. Wegovy maintains stability for 6 weeks at room temperature (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day limit, providing greater travel flexibility. Both medications require 2-8°C refrigerated storage before first use, but Wegovy's extended room temperature tolerance suits active lifestyles better. The FlexTouch pen system delivers precise doses with audible clicks confirming successful injection, whilst the mandatory dose escalation schedule prevents side effects from rapid increases. Weekly injections can be administered any day, with timing flexibility of ±3 days if needed, though consistency improves treatment outcomes.
Personalised Treatment Selection Beyond Dose Equivalency
Rather than focusing solely on Wegovy dose equivalent to Mounjaro, successful prescription weight loss requires personalised treatment selection based on individual factors. Medical history, current medications, lifestyle requirements, and tolerance considerations outweigh simple dose comparisons when choosing between these treatments. Some patients respond better to Wegovy's GLP-1 pathway, whilst others may benefit from Mounjaro's dual-hormone approach, making clinical assessment crucial. Side effect profiles, injection frequency preferences, and storage requirements all influence treatment suitability beyond theoretical dose equivalency.
EverydayMeds' clinical team evaluates these factors during assessment, ensuring appropriate treatment selection rather than applying generic Wegovy dose equivalent to Mounjaro calculations. Both medications require commitment to lifestyle changes including reduced-calorie diet and increased physical activity for optimal results. Our ongoing support helps patients navigate treatment transitions, dose adjustments, and long-term weight management strategies regardless of which prescription-only medicine they choose.
Start Your Weight Loss Journey Today
Don't let confusion about Wegovy dose equivalent to Mounjaro delay your weight management goals—both treatments are available through EverydayMeds with expert clinical guidance. New customers save with code FIRST40, whilst returning patients use DOSE25 at checkout for immediate savings. Our streamlined ordering process, next-day delivery, and registered pharmacy service (GPhC #9012878) provide the support you need for successful prescription weight loss treatment. Complete your 3-minute assessment today at https://everydaymeds.co.uk/collections/wegovy to start your personalised weight management journey. Both Wegovy and Mounjaro are available from EverydayMeds—your prescriber can help determine which is right for you.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
